Tag: clinical kitting

Logistics: Direct-to-Patient IP & Kitting: Operating Blueprint for Scalable Decentralized Trials In the evolving landscape of clinical research, decentralized clinical trials (DCTs) have emerged as a pivotal methodology for increasing patient accessibility and enhancing trial efficiency. This comprehensive guide details the logistics behind direct-to-patient investigational product (IP) distribution and kitting in the framework of scalable…

Read More “Logistics: Direct-to-Patient IP & Kitting: Operating Blueprint for Scalable Decentralized Trials” »

How to Design Logistics: Direct-to-Patient IP & Kitting That Meets FDA, EMA and MHRA Expectations How to Design Logistics: Direct-to-Patient IP & Kitting That Meets FDA, EMA and MHRA Expectations In recent years, the landscape of clinical research has been evolving significantly, with decentralized and hybrid clinical trials leading the charge towards more patient-centric models….

Read More “How to Design Logistics: Direct-to-Patient IP & Kitting That Meets FDA, EMA and MHRA Expectations” »

Logistics: Direct-to-Patient IP & Kitting in Practice: Step-by-Step Guide for Sponsors and CROs Logistics: Direct-to-Patient IP & Kitting in Practice: Step-by-Step Guide for Sponsors and CROs As clinical trials evolve, logistics plays a critical role in the successful execution of decentralized and hybrid clinical trials. Direct-to-Patient (DtP) investigational product (IP) distribution and kitting can significantly…

Read More “Logistics: Direct-to-Patient IP & Kitting in Practice: Step-by-Step Guide for Sponsors and CROs” »

Common Pitfalls in Logistics: Direct-to-Patient IP & Kitting—and How to Avoid Compliance Risks In an era where clinical trials increasingly embrace decentralized and hybrid models, understanding the intricacies of logistics concerning Investigational Product (IP) distribution and kitting is imperative. Particularly for organizations conducting astellas clinical trials, navigating these aspects is critical to ensuring compliance with…

Read More “Common Pitfalls in Logistics: Direct-to-Patient IP & Kitting—and How to Avoid Compliance Risks” »

Aligning Logistics: Direct-to-Patient IP & Kitting With GCP, Telehealth and Home-Based Care Regulations Aligning Logistics: Direct-to-Patient IP & Kitting With GCP, Telehealth and Home-Based Care Regulations As the landscape of clinical trials continues to evolve, particularly with the rise of decentralized and hybrid approaches, the logistical elements of trial management—including investigational product (IP) kitting and…

Read More “Aligning Logistics: Direct-to-Patient IP & Kitting With GCP, Telehealth and Home-Based Care Regulations” »